原文发表于美国时间2021-11-12

强生公司欲将其消费者健康业务部门分拆上市，以开展更有针对性的业务战略并推动业绩增长。

Alex Gorsky将出任强生公司的执行董事长，将首席执行官的职位将在2022年1月3日交接给目前担任公司执行委员会副主席一职的JoaquinDuato。

Joaquin Duato将在集团分拆完成后继续担任新强生公司的领导。

分拆出来的新消费者健康公司的董事会和领导层将在组建过程中确定。

新的消费者健康公司将囊括4个价值10亿美元的知名品牌和20个价值超过1.5亿美元的品牌，这些品牌来自自我养护（OTC）、皮肤健康和基础健康等领域。

分拆的新的消费者健康公司预计将在2021财年创造约150亿美元的营收。

强生公司今后在18至24个月的时间里完成分拆计划。

此外，强生公司预计股东的分红在分拆完成后将维持在同一水平。

价格走势：

在周五文章发表前的盘前交易时段，强生公司的股价上涨2.73%，升至每股167.51美元。

—

点击登录盈透证券中文网站ibkr.com/cn，查看更多盈透证券交易优势

这篇文章已被翻译成中文。原英文作者Benzinga。如英文版本和中文版本之间有任何不一致，以英文版本为准。该文章中的分析仅为提供信息，不是也不应该被视为推销或招揽购买任何证券。文章中讨论的一般市场活动、行业或领域趋势、或其它基于广泛的经济或政治条件的内容，不应被解释为研究结果或投资建议。讨论中提及包括的特定证券、商品、货币、或其它产品均不构成IB推荐购买，出售或持有此类投资的建议。本材料不是也不意图针对个别客户的特定财务条件、投资目标或要求。在根据本材料采取行动之前，您应该考虑是否适合您的具体情况，并在必要时寻求专业建议。

Information posted on IBKR Traders’ Insight that is provided by third-parties and not by Interactive Brokers does NOT constitute a recommendation by Interactive Brokers that you should contract for the services of that third party. Third-party participants who contribute to IBKR Traders’ Insight are independent of Interactive Brokers and Interactive Brokers does not make any representations or warranties concerning the services offered, their past or future performance, or the accuracy of the information provided by the third party. Past performance is no guarantee of future results.

This material is from Benzinga and is being posted with permission from Benzinga. The views expressed in this material are solely those of the author and/or Benzinga and IBKR is not endorsing or recommending any investment or trading discussed in the material. This material is not and should not be construed as an offer to sell or the solicitation of an offer to buy any security. To the extent that this material discusses general market activity, industry or sector trends or other broad based economic or political conditions, it should not be construed as research or investment advice. To the extent that it includes references to specific securities, commodities, currencies, or other instruments, those references do not constitute a recommendation to buy, sell or hold such security. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advise